GE Medical–Mecon merger creates Healthcare Solutions subsidiaryModality vendor enters Web database marketGE Medical Systems has acquired Mecon, a provider of healthcare data mining software, in what appears to be a strategic move to
Modality vendor enters Web database market
GE Medical Systems has acquired Mecon, a provider of healthcare data mining software, in what appears to be a strategic move to continue diversifying its modality systems offerings into healthcare information technologies. Following the acquisition, San Ramon, CA-based Mecon has changed its name to GE Medical Systems Healthcare Solutions. In this transaction, Mecon shareholders received $11.25 per share payable in GE stock, or 0.081 shares of GE stock for each share of Mecon common stock held at the close of the merger, plus cash for fractional shares.
Consistent with its recent emphasis on integration of productivity and workflow (PNN 1/00), Waukesha, WI-based GE will work with the new Healthcare Solutions group to develop Internet-based applications to control costs and provide quality management to customers. Healthcare Solutions claims that its current performance improvement products generally identify 10% to 14% potential savings in operating expenses for customers.
In January, Healthcare Solutions launched two free tools through its Mecon.com Web portal. The Mecon 25th Index allows healthcare providers to compare their actual performance against the top 25% of Mecons customers in its Peernext operational benchmarking database, which creates benchmarks from the data it collects. The BBA Calculator calculates the effect of the Balanced Budget Act of 1997 on operating margin and allows companies to modify inputs to assess effects of budget cuts. However, Mecon does not allow anonymous posting; users must provide the facility name and contact information before logging on to these services.
Because the merger has just been finalized, it is unclear how Mecons products will be affected under the new GE Healthcare Solutions banner. The development of cost control and quality management products that GE and Mecon tout in recent press releases does not perceptibly differ from the benchmarking and data mining products and services that Mecon was already offering, aside from GEs intention to integrate Six Sigma across Healthcare Solutions Web-based databases and benchmarking tools.
© 2000 Miller Freeman, Inc., a United News & Media company.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.